Viewing Study NCT01266161


Ignite Creation Date: 2025-12-24 @ 12:13 PM
Ignite Modification Date: 2025-12-29 @ 7:41 PM
Study NCT ID: NCT01266161
Status: COMPLETED
Last Update Posted: 2018-08-15
First Post: 2010-12-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Multiple Dose Dental Pain Study Of Ibuprofen Extended Release
Sponsor: Pfizer
Organization:

Study Overview

Official Title: A Multiple Dose Dental Pain Study Of An Ibuprofen 600 Mg Extended Release Caplet
Status: COMPLETED
Status Verified Date: 2018-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study hypothesis is that single and multiple doses of ibuprofen 600 mg ER caplets provide analgesic efficacy superior to placebo over 12-hour dosing intervals.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
AK-10-13 OTHER Alias Study Number View